Patents Assigned to Austria Wirtschaftsservice Gesellschaft mit beschrankter Haftung
-
Patent number: 7928187Abstract: The present invention describes a polypeptide, comprising the amino acid sequence APAHRSSTFPKWVTKTERGRQPLRS (Seq. ID. No.1) or a fragment thereof, said fragment comprising at least 7 consecutive amino acid residues of Seq. ID. No.1.Type: GrantFiled: March 7, 2006Date of Patent: April 19, 2011Assignee: Austria Wirtschaftsservice Gesellschaft mit beschrankter HaftungInventors: Barbara Kofler, Kerstin Moritz, Katrin Fenninger
-
Patent number: 7772402Abstract: The invention relates to compounds having general formula I in which X represents an optically detectable moiety, n is an integer with 1?n?20, R1 is an unbranched or branched alkyl group having 1 to 20 carbon atoms, and R2 is hydrogen or —CH2—O—R3 group, wherein R3 has the same meaning as R1. These compounds are useful as inhibitors of lipolytic enzymes and can be used as tools for analysis as well as discrimination of lipolytic enzymes in biological samples.Type: GrantFiled: June 23, 2009Date of Patent: August 10, 2010Assignee: Austria Wirtschaftsservice Gesellschaft Mit Beschrankter HaftungInventors: Albin Hermetter, Olga Oskolkova
-
Publication number: 20090258422Abstract: The invention relates to compounds having general formula I in which X represents an optically detectable moiety, n is an integer with 1?n?20, R1 is an unbranched or branched alkyl group having 1 to 20 carbon atoms, and R2 is hydrogen or —CH2—O—R3 group, wherein R3 has the same meaning as R1. These compounds are useful as inhibitors of lipolytic enzymes and can be used as tools for analysis as well as discrimination of lipolytic enzymes in biological samples.Type: ApplicationFiled: June 23, 2009Publication date: October 15, 2009Applicant: AUSTRIA WIRTSCHAFTSSERVICE GESELLSCHAFT MIT BESCHRANKTER HAFTUNGInventors: Albin HERMETTER, Olga Oskolkova
-
Patent number: 7601845Abstract: The invention relates to compounds having general formula I in which X represents an optically detectable moiety, n is an integer with 1?n?20, R1 is an unbranched or branched alkyl group having 1 to 20 carbon atoms, and R2 is hydrogen or —CH2—O—R3 group, wherein R3 has the same meaning as R1. These compounds are useful as inhibitors of lipolytic enzymes and can be used as tools for analysis as well as discrimination of lipolytic enzymes in biological samples.Type: GrantFiled: September 16, 2005Date of Patent: October 13, 2009Assignee: Austria Wirtschaftsservice Gesellschaft mit beschrankter HaftungInventors: Albin Hermetter, Olga Oskolkova
-
Patent number: 7419508Abstract: The invention relates to a light prosthesis as a purely optical substitute for a missing limb, including a shaped body (1) for replacing the missing limb as naturally as possible and a socket (2) for connecting the prosthesis to the stump (3) of the missing limb. In order to provide such a prosthesis for temporary or permanent use without having to fulfill any functionality, thus being suitable also for elderly patients, it is contemplated that the shaped body (1) is made of a light synthetic material, and that the periphery of the socket (2) for connecting the prosthesis to the stump (3) is variable in a manner known per se. The shaped body (1) may, in particular, also be made of an elastic, air-tight synthetic material (9) and include at least one valve (10) for inflating the shaped body (1).Type: GrantFiled: July 23, 2004Date of Patent: September 2, 2008Assignees: Austria Wirtschaftsservice Gesellschaft Mit Beschrankter HaftungInventor: Heide-Marie Holzer
-
Patent number: 7112680Abstract: The invention relates to novel 2-benzimidazolyl-, 2-benzoxazolyl- and 2-benzothiazolyl hydrazones that are derived from 2-formylpyridine, 2-acylpyridines, acetyldiazines and acetyl(iso)quinolines. The invention also relates to a novel method for producing 2-benzimidazolyl-, 2-benzoxazolyl- and 2-benzothiazolyl hydrazones and to their use as useful anti-cancer therapeutic agents. The novel compounds are also active against multidrug-resistant cancer cells.Type: GrantFiled: June 5, 2001Date of Patent: September 26, 2006Assignee: Austria Wirtschaftsservice Gesellschaft MIT Beschrankter HaftungInventors: Johann Hofmann, Gottfried Heinisch, Johnny Easmon, Gerhard Pürstinger, Heinz-Herbert Fiebig
-
Patent number: 7084442Abstract: The invention involves an array to couple a live cell, in particular a nerve cell, with an electronic circuit to pick up directly or indirectly electrically active cell signals and/or to electronically stimulate the cell, where the coupling array comprises a transistor (T1) with a double gate, where one of the gates is designed as a control gate (CG) to select the transistor via external control signals, and the other gate (FG) is connected to an electrically conducting contact element (1) which may be brought into contact with the cell (2) to register changes in the electric properties of the cell.Type: GrantFiled: August 19, 2004Date of Patent: August 1, 2006Assignee: Austria Wirtschaftsservice Gesellschaft mit beschrankter HaftungInventor: Emmerich Bertagnolli
-
Publication number: 20060134715Abstract: The invention relates to compounds having general formula I in which X represents an optically detectable moiety, n is an integer with 1?n?20, R1 is an unbranched or branched alkyl group having 1 to 20 carbon atoms, and R2 is hydrogen or —CH2—O—R3 group, wherein R3 has the same meaning as R1. These compounds are useful as inhibitors of lipolytic enzymes and can be used as tools for analysis as well as discrimination of lipolytic enzymes in biological samples.Type: ApplicationFiled: September 16, 2005Publication date: June 22, 2006Applicant: Austria Wirtschaftsservice Gesellschaft Mit Beschrankter HaftungInventors: Albin Hermetter, Olga Oskolkova